NEXTLEAP Cold Sore Care

NEXTLEAP Cold Sore Care

Early Stage

A new breakthrough treatment approach for cold sores-Return to Normal in 1-2 Days!

A new breakthrough treatment approach for cold sores-Return to Normal in 1-2 Days!

Overview

Raised to Date: Raised: $106,800

Total Commitments ($USD)

Platform

Wefunder

Start Date

02/01/2024

Close Date

04/29/2024

Min. Goal
$50,000
Max. Goal
$1,230,000
Min. Investment

$100

Security Type

Convertible Note

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$12,000,000

Discount

20%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

05/04/2024

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,228

# of Investors

26

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Medium

Capital Intensity

Low

Location

Dallas, Texas

Business Type

Growth

NEXTLEAP Cold Sore Care, with a valuation of $12 million, is raising funds on Wefunder. The company has developed a new breakthrough treatment for cold sores. NEXTLEAP Cold Sore Care’s IP-protected product gives new and improved results for cold sore treatment and reduces the appearance of skin discoloration. The business has a loyal customer base and reported a 300% monthly sales growth over the last year. Frank Murdock and Paul Stewart founded NEXTLEAP Cold Sore Care in August 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.23 million. The campaign proceeds will be used for sales and marketing and general administrative expenses.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$753

$0

COGS

$84

$0

Tax

$0

$0

 

 

Net Income

$-78,378

$0

Summary Balance Sheet

FY 2022 FY 2021

Cash

$16,118

$0

Accounts Receivable

$0

$0

Total Assets

$84,384

$0

Short-Term Debt

$161,762

$0

Long-Term Debt

$0

$0

Total Liabilities

$161,762

$0

Financials as of: 02/01/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
NEXTLEAP Cold Sore Care on Wefunder 2024
Platform: Wefunder
Security Type: Convertible Note
Valuation: $12,000,000

Follow company

Follow NEXTLEAP Cold Sore Care on Wefunder 2024

Buy NEXTLEAP Cold Sore Care's Deal Report

Warning: according to the close date for this deal, NEXTLEAP Cold Sore Care may no longer be accepting investments.

NEXTLEAP Cold Sore Care Deal Report

Get KingsCrowd’s comprehensive report on NEXTLEAP Cold Sore Care including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether NEXTLEAP Cold Sore Care is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the NEXTLEAP Cold Sore Care deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge